Christopher A. Lipinski is a medicinal chemist who is working at Pfizer, Inc. He is known for his "rule of five", an algorithm that predicts drug compounds that are likely to have oral activity. By the number of citations, he is the most cited author of some pharmacology journals: Journal of Pharmacological and Toxicological Methods,

Advanced Drug Delivery Reviews ''Advanced Drug Delivery Reviews'' is a Peer review, peer-reviewed medical journal covering research involving the controlled release and delivery of drugs and other biologically active agents. The editor-in-chief is H. Ghandehari. Abstracting a ...

, Drug Discovery Today: Technologies. Lipinski received his PhD from the University of California, Berkeley in 1968 in physical organic chemistry. The ''

'' article reporting his "rule of five" is one of the most cited publications in the journal's history. In 2006, he received an honorary law degree from the University of Dundee and he has won various awards, including being the Society for Biomolecular Sciences' winner of the 2006 SBS Achievement Award for Innovation in HTS.

References

{{DEFAULTSORT:Lipinski, Christopher A University of California, Berkeley alumni Year of birth missing (living people) Living people 20th-century American chemists 21st-century American chemists Pfizer people Place of birth missing (living people) Computational chemists Drug discovery